Healthcare
Quanterix Corporation(QTRX)
Live Price
Offline$3.39
+17.71% today
1Y Change
-50.79%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $160.00M
- Revenue Growth
- +2.6%
- EPS Growth
- -151.0%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Quanterix Corporation (QTRX) is a Healthcare stock with a market cap of $160.00M and listed on NASDAQ. The stock last traded around $3.39 and down 50.8% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +2.6%, EPS growth of -151.0%, a dividend yield of 0.0%. What stands out right now is revenue +2.6%, EPS -151.0%, free cash flow -107.2% with operating margin -89.9% and ROIC -33.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines QTRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+2.6% vs +7.6% peer median
Operating Margin
Below sector median
-89.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +2.6% and EPS is at -151.0%, with operating margin around -89.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -7.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | +3.9% | -10.0% | +10.4% |
2026 Mar 2, 2026 | -40.7% | -7.3% | -19.4% | -45.8% |
2025 Nov 10, 2025 | -56.5% | -2.3% | +8.0% | +49.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QTRX
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
QTRX Max Drawdown
-68.86%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for QTRX and SPY.
Company Overview
Quanterix Corporation
NASDAQ Global Market
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
- Leadership
- Everett V. Cunningham
- IPO Date
- Dec 7, 2017
- Employees
- 471
- Street Address
- Building 1
- Mailing
- Billerica, MA, 01821
- Region
- Billerica, MA, US
- Reporting Currency
- USD
- Investor Line
- 617 301 9400
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 1.2
- Price/Book
- 0.5
Growth
- Revenue
- +2.6%
- EPS
- -151.0%
- Free Cash Flow
- -107.2%
Profitability
- Gross Margin
- 46.6%
- Operating Margin
- -89.9%
- Net Margin
- -77.2%
- ROE
- -35.2%
- ROIC
- -33.8%
Balance Sheet
- Debt/Equity
- 0.13
- Current Ratio
- 2.84
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.